CRISPR-based gene editing: Targeted gene-editing approaches can be used to study the specific contribution of AMD-associated risk alleles (CFH, ARMS2/HTRA1, C3) and their role in immune dysregulation and oxidative stress resistance in RPE cells. The gene discussed is ARMS2; the disease is age-related macular degeneration.